FGF23 and chronic kidney disease: In the second phase of study, the CKD-MBD markers at week 24, namely: iPTH, and FGF-23, were significantly decreased from the baseline and markedly rebound at week 12 after discontinuation of cinacalcet (Table 1), suggesting that the long term treatment is needed for controlling these disorders.